US buys 200M more COVID-19 vaccine doses from Pfizer

The U.S. purchased an additional 200 million doses of Pfizer’s COVID-19 vaccine, the drugmaker said July 23.

Advertisement

Pfizer expects to deliver 110 million doses by Dec. 31, with the remaining 90 million doses expected to be delivered by April 30.

The U.S. also has the option to obtain an updated version of the vaccine designed to target coronavirus variants, should one be authorized.

The deal brings the total number of Pfizer doses purchased by the U.S. government to 500 million.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.